Advertisement
U.S. markets closed
Advertisement

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
5.87+0.26 (+4.63%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close5.61
Open5.50
Bid5.78 x 800
Ask5.95 x 800
Day's Range5.44 - 5.89
52 Week Range1.75 - 11.00
Volume21,726
Avg. Volume24,569
Market Cap285.557M
Beta (5Y Monthly)1.31
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NBTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nanobiotix S.A.
    Daily – Vickers Top Buyers & Sellers for 08/19/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • Investopedia

    Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen Pharmaceutical

    American depositary receipts of Nanobiotix jumped over 50% in early trading on Monday after signing an agreement with J&J's Janssen Pharmaceutical to work on co-developing a drug to treat head and neck cancer tumors.

  • Benzinga

    Nanobiotix Stock Triples In Trading Session: What's Going On With Stock On Friday

    Nanobiotix (NASDAQ: NBTX) shares gained more than 200% on Friday trading after it entered into final contract negotiations with a major global pharmaceutical company. In its Q4 earnings release, Nanobiotix raised going concerns. The company noted net losses of €57.0 million in 2022 and a net decrease in cash and cash equivalents of €42.5 million in 2022. Nanobiotix stock is gaining on heavy volume, with a session volume of 30.262 million shares traded. The company agreed to a non-binding term sh